Cite
HARVARD Citation
Duso, B. et al. (2019). An analysis of available biomarker data for targeting cyclin-dependent kinases 4 and 6 (CDK4/6) in breast cancer. Expert review of precision medicine and drug development. 4 (3), pp. 129-138. [Online].